Literature DB >> 28541467

Global epidemiology of CTX-M β-lactamases: temporal and geographical shifts in genotype.

Edward R Bevan1,2, Annie M Jones3, Peter M Hawkey1,2.   

Abstract

Globally, rates of ESBL-producing Enterobacteriaceae are rising. We undertook a literature review, and present the temporal trends in blaCTX-M epidemiology, showing that blaCTX-M-15 and blaCTX-M-14 have displaced other genotypes in many parts of the world. Explanations for these changes can be attributed to: (i) horizontal gene transfer (HGT) of plasmids; (ii) successful Escherichia coli clones; (iii) ESBLs in food animals; (iv) the natural environment; and (v) human migration and access to basic sanitation. We also provide explanations for the changing epidemiology of blaCTX-M-2 and blaCTX-M-27. Modifiable anthropogenic factors, such as poor access to basic sanitary facilities, encourage the spread of blaCTX-M and other antimicrobial resistance (AMR) genes, such as blaNDM, blaKPC and mcr-1. We provide further justification for novel preventative and interventional strategies to reduce transmission of these AMR genes.
© The Author 2017. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28541467     DOI: 10.1093/jac/dkx146

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  172 in total

1.  Molecular Epidemiology of Dairy Cattle-Associated Escherichia coli Carrying blaCTX-M Genes in Washington State.

Authors:  Josephine A Afema; Sara Ahmed; Thomas E Besser; Lisa P Jones; William M Sischo; Margaret A Davis
Journal:  Appl Environ Microbiol       Date:  2018-03-01       Impact factor: 4.792

2.  Combination of Amino Acid Substitutions Leading to CTX-M-15-Mediated Resistance to the Ceftazidime-Avibactam Combination.

Authors:  Fabrice Compain; Delphine Dorchène; Michel Arthur
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

3.  Understanding drug resistance will improve the treatment of bacterial infections.

Authors:  Laura J V Piddock
Journal:  Nat Rev Microbiol       Date:  2017-10-12       Impact factor: 60.633

Review 4.  Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Update on Molecular Epidemiology and Treatment Options.

Authors:  Gisele Peirano; Johann D D Pitout
Journal:  Drugs       Date:  2019-09       Impact factor: 9.546

5.  Wastewater as a Probable Environmental Reservoir of Extended-Spectrum-β-Lactamase Genes: Detection of Chimeric β-Lactamases CTX-M-64 and CTX-M-123.

Authors:  Hayato Tanaka; Wataru Hayashi; Masaki Iimura; Yui Taniguchi; Eiji Soga; Nao Matsuo; Kumiko Kawamura; Yoshichika Arakawa; Yukiko Nagano; Noriyuki Nagano
Journal:  Appl Environ Microbiol       Date:  2019-10-30       Impact factor: 4.792

6.  Conjugative plasmids interact with insertion sequences to shape the horizontal transfer of antimicrobial resistance genes.

Authors:  You Che; Yu Yang; Xiaoqing Xu; Karel Břinda; Martin F Polz; William P Hanage; Tong Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-09       Impact factor: 11.205

7.  Independent Host Factors and Bacterial Genetic Determinants of the Emergence and Dominance of Escherichia coli Sequence Type 131 CTX-M-27 in a Community Pediatric Cohort Study.

Authors:  André Birgy; Corinne Levy; Marie-Hélène Nicolas-Chanoine; Aurélie Cointe; Claire A Hobson; Mélanie Magnan; Stéphane Bechet; Philippe Bidet; Robert Cohen; Stéphane Bonacorsi
Journal:  Antimicrob Agents Chemother       Date:  2019-06-24       Impact factor: 5.191

8.  Comparative Activities of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Enterobacteriaceae Isolates Producing Extended-Spectrum β-Lactamases from U.S. Hospitals.

Authors:  Mariana Castanheira; Timothy B Doyle; Rodrigo E Mendes; Helio S Sader
Journal:  Antimicrob Agents Chemother       Date:  2019-06-24       Impact factor: 5.191

9.  WCK 5222 (Cefepime/Zidebactam) Pharmacodynamic Target Analysis against Metallo-β-lactamase producing Enterobacteriaceae in the Neutropenic Mouse Pneumonia Model.

Authors:  Alexander J Lepak; Miao Zhao; David R Andes
Journal:  Antimicrob Agents Chemother       Date:  2019-10-07       Impact factor: 5.191

10.  Activity of Ertapenem against Enterobacteriaceae in seven global regions-SMART 2012-2016.

Authors:  Sibylle H Lob; Meredith A Hackel; Daryl J Hoban; Katherine Young; Mary R Motyl; Daniel F Sahm
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-05-12       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.